Literature DB >> 3861655

Antibiotic susceptibility of anaerobic bacteria from the human oral cavity.

P J Baker, R T Evans, J Slots, R J Genco.   

Abstract

Anaerobic, agar-dilution, minimal inhibitory concentrations (MICs) of 18 antibiotics are given for the numerically important bacterial groups from the human oral cavity. Strains are divided into susceptibility categories using the guidelines for interpretation of MICs suggested by the National Committee for Clinical Laboratory Standards. These guidelines are based on data on antibiotic concentrations attainable in serum following various dosage regimens. MICs are also compared with attainable gingival fluid levels where these are known. The highest percentages of strains were susceptible to tetracycline, with 89% of the 139 strains tested susceptible to serum levels and 97% conditionally susceptible to attainable gingival fluid levels. Ninety-eight percent of strains were conditionally susceptible to attainable gingival fluid levels of minocycline, but many strains, including Actinobacillus actinomycetemcomitans, were only moderately susceptible to attainable serum levels of this tetracycline analogue. Carbenicillin was effective against most groups of organisms, with the important exception of A. actinomycetemcomitans, at serum levels attainable with oral formulations of carbenicillin. Only 2% of the total strains tested were resistant to penicillin, while 33% of strains were categorized as moderately susceptible. Clindamycin was active against many strains of Gram-negative bacteria but was not active against A. actinomycetemcomitans, some Bacteroides, Eikenella corrodens, or the anaerobic vibrios. Metronidazole was active against A. actinomycetemcomitans, all five groups of oral Bacteroides tested, and against Capnocytophaga species. Chloramphenicol was active against A. actinomycetemcomitans, but not against most of the other groups of oral organisms. Nearly all groups contained strains non-susceptible to serum levels attainable with the usual doses of erythromycin, spiramycin, vancomycin, kanamycin, neomycin, streptomycin, doxycycline, oxytetracycline, or chlortetracycline; several strains were resistant to maximum attainable serum levels of each of these antibiotics except doxycycline.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3861655     DOI: 10.1177/00220345850640101201

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  9 in total

1.  In vitro susceptibilities of oral bacterial isolates to spiramycin.

Authors:  E C Chan; W al-Joburi; S L Cheng; F Delorme
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

2.  In vitro susceptibilities of suspected periodontopathic anaerobes as determined by membrane transfer assay.

Authors:  P W Caufield; D N Allen; N K Childers
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

Review 3.  Biology of asaccharolytic black-pigmented Bacteroides species.

Authors:  D Mayrand; S C Holt
Journal:  Microbiol Rev       Date:  1988-03

4.  Characterization of Bacteroides forsythus isolates.

Authors:  T Takemoto; H Kurihara; G Dahlen
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

5.  Effect of clindamycin on neutrophil killing of gram-negative periodontal bacteria.

Authors:  P J Baker; M E Wilson
Journal:  Antimicrob Agents Chemother       Date:  1988-10       Impact factor: 5.191

6.  In vitro activity of azithromycin compared with that of erythromycin against Actinobacillus actinomycetemcomitans.

Authors:  R Pajukanta; S Asikainen; M Saarela; S Alaluusua; H Jousimies-Somer
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

7.  Subinhibitory concentrations of cefpodoxime alter membrane protein expression of Actinobacillus actinomycetemcomitans and enhance its susceptibility to killing by neutrophils.

Authors:  P J Baker; W F Busby; M E Wilson
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

8.  Clindamycin versus phenoxymethylpenicillin in the treatment of acute orofacial infections.

Authors:  L von Konow; P A Köndell; C E Nord; A Heimdahl
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-12       Impact factor: 3.267

9.  A pilot study to evaluate the effectiveness of adjunctive use of two antimicrobial topical gels in chronic gingivitis.

Authors:  Priyanka Mishra; Anuj Bhargava; Neha Nigam-Gupta
Journal:  J Clin Exp Dent       Date:  2021-04-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.